Your session is about to expire
← Back to Search
Combination Training + Visual Sensitivity Training for Macular Degeneration(FLAP Trial)
FLAP Trial Summary
This trial seeks to better understand how the brain adapts to vision loss in order to develop new therapies to improve quality of life for those with low vision.
- Age-Related Macular Degeneration
- Central Vision Loss
FLAP Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
FLAP Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
FLAP Trial Design
Find a Location
Who is running the clinical trial?
- You have a lot of tattoos, especially near your head, that are very old or have bright colors.You have braces or a permanent retainer.You are between 18 and 89 years old.You have very poor vision in both eyes (20/100 or worse).You experience seeing or hearing things that are not real, or having strong beliefs that are not based on reality.You have hearing problems.Your body is larger than 60 inches around at its widest point.You have had a severe head injury in the past.You have a pacemaker or any metal inside your body that can be affected by magnets.You are afraid of being in small or enclosed spaces.You weigh more than 300 pounds.You have been diagnosed with macular degeneration by an eye doctor.You have more severe light sensitivity in the center of your retina compared to the edges.Your medical records show that you have had this level of illness for at least 2 years.
- Group 1: Combination training
- Group 2: Training visual sensitivity
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an opportunity for me to partake in this research?
"This clinical trial seeks to enroll 60 individuals with macular degeneration aged between 18 and 89 years old. In order to be eligible, they must also have severely impaired vision in both eyes (20/100 or worse), a prior diagnosis of Macular Degeneration by an Ophthalmologist, light sensitivity in the macula that is at least 10 dB units more than peripheral regions as confirmed using MAIA technology scans, and documented evidence indicating a minimum two year period of this level of eye disease severity."
Is the recruitment process for this experiment still open?
"Affirmed, the clinical trial is currently recruiting participants. The data posted on clinicaltrials.gov indicates that this experiment was initiated November 1st 2022 and its records were most recently amended October 31st 2022."
How many participants has this research initiative recruited?
"Affirmative, the clinicaltrials.gov website states that this trial is currently seeking participants. It was first posted on November 1st 2022 and has seen its last update on October 31st 2022. 60 patients are planned to be enrolled from a single medical site."
Does this trial accept participants aged twenty or more?
"This trial is seeking adult participants aged 18 and under 89."
Share this study with friends